Anticancer Research: 39 (3)

Index by author

March 2019; Volume 39,Issue 3

Reviews

You have access
GastroPanel® Biomarker Assay: The Most Comprehensive Test for Helicobacter pylori Infection and Its Clinical Sequelae. A Critical Review
KARI SYRJÄNEN, MATTI ESKELINEN, ANTS PEETSALU, TOOMAS SILLAKIVI, PENTTI SIPPONEN, MATTI HÄRKÖNEN, LEA PALOHEIMO, MINNA MÄKI, TAPANI TIUSANEN, OSMO SUOVANIEMI, FRANCESCO DiMARIO and ZHU PING FAN

Anticancer Research March 2019, 39 (3) 1091-1104; DOI: https://doi.org/10.21873/anticanres.13218
You have access
Bladder Organoids and Spheroids: Potential Tools for Normal and Diseased Tissue Modelling
IGOR VASYUTIN, LILLIAN ZERIHUN, CRISTINA IVAN and ANTHONY ATALA

Anticancer Research March 2019, 39 (3) 1105-1118; DOI: https://doi.org/10.21873/anticanres.13219
You have access
Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma
ELEFTHERIOS SPARTALIS, DIMITRIOS I. ATHANASIADIS, DIMOSTHENIS CHRYSIKOS, MICHAEL SPARTALIS, GEORGIOS BOUTZIOS, DIMITRIOS SCHIZAS, NIKOLAOS GARMPIS, CHRISTOS DAMASKOS, STAVROULA A. PASCHOU, ARGYRIOS IOANNIDIS, GERASIMOS TSOUROUFLIS, DIMITRIOS DIMITROULIS and NIKOLAOS I. NIKITEAS

Anticancer Research March 2019, 39 (3) 1119-1127; DOI: https://doi.org/10.21873/anticanres.13220

Experimental Studies

You have access
β-Catenin Expression Correlates With Prognosis in Hepatocellular Carcinoma Patients Treated With Transcatheter Arterial Chemoembolization
XIANGXIAN XU, DAZHI GAO, XIAOLI YUAN, LI LIU, XIANG ZHANG, XIANXIAN LIANG, SUI CHEN, MIN AI, BO CHEN, DONGHONG SHI, ZHIJIAN YANG, ROBERT M. HOFFMAN and JIAN XU

Anticancer Research March 2019, 39 (3) 1129-1134; DOI: https://doi.org/10.21873/anticanres.13221
You have access
Neutron-induced Rat Mammary Carcinomas Are Mainly of Luminal Subtype and Have Multiple Copy Number Aberrations
HITOMI MORIYAMA, KAZUHIRO DAINO, TATSUHIKO IMAOKA, MAYUMI NISHIMURA, YUKIKO NISHIMURA, MASARU TAKABATAKE, TAKAMITSU MORIOKA, MASAHIRO FUKUSHI, YOSHIYA SHIMADA and SHIZUKO KAKINUMA

Anticancer Research March 2019, 39 (3) 1135-1142; DOI: https://doi.org/10.21873/anticanres.13222
You have access
SIRT1 Expression Is Associated With Cell Proliferation in Angiosarcoma
MOTOHIRO CHOSOKABE, AKIRA NOGUCHI, MASAHIRO HOSHIKAWA, MIKIO MASUZAWA and MASAYUKI TAKAGI

Anticancer Research March 2019, 39 (3) 1143-1150; DOI: https://doi.org/10.21873/anticanres.13223
You have access
Minichromosome Maintenance Proteins MCM-3, MCM-5, MCM-7, and Ki-67 as Proliferative Markers in Adrenocortical Tumors
MICHAL APOROWICZ, PIOTR CZOPNIK, ELIZA KUBICKA, ALEKSANDRA PIOTROWSKA, PIOTR DZIEGIEL, MAREK BOLANOWSKI and PAWEL DOMOSLAWSKI

Anticancer Research March 2019, 39 (3) 1151-1159; DOI: https://doi.org/10.21873/anticanres.13224
You have access
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia Cells
GORDON T. BOLGER, ALBERT LICOLLARI, RICHARD BAGSHAW, AIMIN TAN, RICHARD GREIL, BRIGITTA VCELAR, MUHAMMED MAJEED and PETER SORDILLO

Anticancer Research March 2019, 39 (3) 1161-1168; DOI: https://doi.org/10.21873/anticanres.13225
You have access
Targeted and Efficient Delivery of siRNA Using Tunable Polymeric Hybrid Micelles for Tumor Therapy
FEI HAO, SHIYAN DONG, CHUNMIAO YANG, ZIWEI LI, ZIYUAN CHENG, LIHUANG ZHONG, LIRONG TENG, QINGFAN MENG, JIAHUI LU, FAN WU, JING XIE, LESHENG TENG and ROBERT J. LEE

Anticancer Research March 2019, 39 (3) 1169-1178; DOI: https://doi.org/10.21873/anticanres.13226
You have access
Liprin-α4 as a New Therapeutic Target for SCLC as an Upstream Mediator of HIF1α
HIDEYA ONISHI, AKIO YAMASAKI, KATSUYA NAKAMURA, SHU ICHIMIYA, KOSUKE YANAI, MASAYO UMEBAYASHI, SHUNTARO NAGAI and TAKASHI MORISAKI

Anticancer Research March 2019, 39 (3) 1179-1184; DOI: https://doi.org/10.21873/anticanres.13227
You have access
Association of Matrix Metallopeptidase-2 Promoter Polymorphisms With the Risk of Childhood Leukemia
PEI-CHEN HSU, JEN-SHENG PEI, CHAO-CHUN CHEN, WEN-SHIN CHANG, CHIEN-CHUNG KUO, SHUN-PING CHENG, CHIA-WEN TSAI, DA-TIAN BAU and CHI-LI GONG

Anticancer Research March 2019, 39 (3) 1185-1190; DOI: https://doi.org/10.21873/anticanres.13228
You have access
Increase of CD45-positive Immune Cells in Liver Parenchyma Indicates a More Favorable Prognosis for Patients With Barrett's Cancer
MARIUS KEMPER, TIMO STROHM, KATHARINA GRUPP, TARIK GHADBAN, DEAN BOGOEVSKI, KAI BACHMANN, MAXIMILIAN BOCKHORN, GUIDO SAUTER, JAKOB R. IZBICKI and MATTHIAS REEH

Anticancer Research March 2019, 39 (3) 1191-1196; DOI: https://doi.org/10.21873/anticanres.13229
You have access
Antibiotic Tetrocarcin-A Down-regulates JAM-A, IAPs and Induces Apoptosis in Triple-negative Breast Cancer Models
SRI HARIKRISHNA VELLANKI, RODRIGO G.B. CRUZ, CATHY E. RICHARDS, YVONNE E. SMITH, LANCE HUDSON, HANNE JAHNS and ANN M. HOPKINS

Anticancer Research March 2019, 39 (3) 1197-1204; DOI: https://doi.org/10.21873/anticanres.13230
You have access
Induced Pluripotent Stem Cell-related Genes Correlate With Poor Prognoses of Oral Squamous Cell Carcinoma
YUMI MURAKI, TAKUMI HASEGAWA, DAISUKE TAKEDA, TAKESHI UEHA, EIJI IWATA, IZUMI SAITO, RIKA AMANO, AKIKO SAKAKIBARA, MASAYA AKASHI and TAKAHIDE KOMORI

Anticancer Research March 2019, 39 (3) 1205-1216; DOI: https://doi.org/10.21873/anticanres.13231
You have access
A Standardized Evaluation Method for FOXP3+ Tregs and CD8+ T-cells in Breast Carcinoma: Association With Breast Carcinoma Subtypes, Stage and Prognosis
ELENI PAPAIOANNOU, MINAS SAKELLAKIS, MARIA MELACHRINOU, EVANGELOS TZORACOLEFTHERAKIS, HARALAMBOS KALOFONOS and ELENI KOUREA

Anticancer Research March 2019, 39 (3) 1217-1232; DOI: https://doi.org/10.21873/anticanres.13232
You have access
Clinicopathological Significance of Autophagy-related Proteins and its Association With Genetic Alterations in Gliomas
SAMANTHA TAMRAKAR, MASAKAZU YASHIRO, TOSHIYUKI KAWASHIMA, TAKEHIRO UDA, YUZO TERAKAWA, YUKO KUWAE, MASAHIKO OHSAWA and KENJI OHATA

Anticancer Research March 2019, 39 (3) 1233-1242; DOI: https://doi.org/10.21873/anticanres.13233
You have access
Anticancer Potential of Oleuropein, the Polyphenol of Olive Oil, With 2-Methoxyestradiol, Separately or in Combination, in Human Osteosarcoma Cells
PAULINA PRZYCHODZEN, ROKSANA WYSZKOWSKA, MONIKA GORZYNIK-DEBICKA, TOMASZ KOSTRZEWA, ALICJA KUBAN-JANKOWSKA and MAGDALENA GORSKA-PONIKOWSKA

Anticancer Research March 2019, 39 (3) 1243-1251; DOI: https://doi.org/10.21873/anticanres.13234
You have access
Digital Analysis of BCL2 Expression in Laryngeal Squamous Cell Carcinoma
ARISTEIDIS CHRYSOVERGIS, VASILEIOS S. PAPANIKOLAOU, EVANGELOS TSIAMBAS, VASILEIOS RAGOS, DIMITRIOS PESCHOS and EFTHYMIOS KYRODIMOS

Anticancer Research March 2019, 39 (3) 1253-1257; DOI: https://doi.org/10.21873/anticanres.13235
You have access
Osteonecrosis in Children and Adolescents With Acute Lymphoblastic Leukemia: Early Diagnosis and New Treatment Strategies
GIADA BIDDECI, GERARDO BOSCO, ELENA VAROTTO, MARCO CORRADIN, GIULIA GERANIO, GLORIA TRIDELLO, MARTA PILLON, ELISA CARRARO, GIACOMO GARETTO, ROYA ASSADI, COSIMO GIGANTE and MARIA CATERINA PUTTI

Anticancer Research March 2019, 39 (3) 1259-1266; DOI: https://doi.org/10.21873/anticanres.13236
You have access
ROBO1 Expression in Metastasizing Breast and Ovarian Cancer: SLIT2-induced Chemotaxis Requires Heparan Sulfates (Heparin)
GÜNTHER A. REZNICZEK, CHRISTINE GRUNWALD, ZIAD HILAL, JAN SCHEICH, GUIDO REIFENBERGER, ANDREA TANNAPFEL and CLEMENS B. TEMPFER

Anticancer Research March 2019, 39 (3) 1267-1273; DOI: https://doi.org/10.21873/anticanres.13237
You have access
Relationship Between EGFR Expression in Oral Cancer Cell Lines and Cetuximab Antibody-dependent Cell-mediated Cytotoxicity
HIROSHI NAKAMURA, SHIGEHIRO TAMAKI, TAKAHIRO YAGYUU, NOBUHIRO YAMAKAWA, KATSUHIKO HATAKE and TADAAKI KIRITA

Anticancer Research March 2019, 39 (3) 1275-1282; DOI: https://doi.org/10.21873/anticanres.13238
You have access
Genomic Instability and Cytotoxicity in Buccal Mucosal Cells of Workers in Banana Farming Evaluated by Micronucleus Test
SAMUEL RANGEL CLAUDIO, JOSE MARTIM MARQUES SIMAS, ANA CAROLINA FLYGARE SOUZA, MARIA DO CARMO BARACHO DE ALENCAR, LIRIA YURI YAMAUCHI and DANIEL ARAKI RIBEIRO

Anticancer Research March 2019, 39 (3) 1283-1286; DOI: https://doi.org/10.21873/anticanres.13239

Clinical Studies

You have access
The Influence of Single Nucleotide Polymorphisms and Adjuvant Radiotherapy on Systemic Inflammatory Proteins, Chemokines and Cytokines of Patients With Breast Cancer
NONGNIT LAYTRAGOON LEWIN, THITIYA LUETRAGOON, BENGT-ÅKE ANDERSSON, DELMY OLIVA, MATS NILSSON, MICHAEL STRANDEUS, STURE LÖFGREN, LARS-ERIK RUTQVIST and FREDDI LEWIN

Anticancer Research March 2019, 39 (3) 1287-1292; DOI: https://doi.org/10.21873/anticanres.13240
You have access
Combined Testing of p16 Tumour-suppressor Protein and Human Papillomavirus in Patients With Oral Leukoplakia and Oral Squamous Cell Carcinoma
JONAS SUNDBERG, MAGDALENA KORYTOWSKA, PATRICIA MIRANDA BURGOS, JOHAN BLOMGREN, LENA BLOMSTRAND, SHAHIN DE LARA, LARS SAND, JAN-MICHÁEL HIRSCH, ERIK HOLMBERG, DANIEL GIGLIO, JENNY ÖHMAN, ANIKÓ KOVÁCS, PETER HORAL, MAGNUS LINDH, GÖRAN KJELLER and BENGT HASSÉUS

Anticancer Research March 2019, 39 (3) 1293-1300; DOI: https://doi.org/10.21873/anticanres.13241
You have access
Enhancement of the Marginal Area in Colorectal Cancer Liver Metastasis on Computed Tomography Correlates With Microvessel Density and Clinicopathological Factors
YUKI YANO, KAZUHIKO YOSHIMATSU, HAJIME YOKOMIZO, MASANO SAGAWA, HIROKO ITAGAKI and YOSHIHIKO NARITAKA

Anticancer Research March 2019, 39 (3) 1301-1308; DOI: https://doi.org/10.21873/anticanres.13242
You have access
Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue Sarcomas
MYRELLA VLENTERIE, WIM JG OYEN, NEELTJE STEEGHS, INGRID M.E. DESAR, REMY B. VERHEIJEN, ANNE MIEK KOENEN, WILLEM GROOTJANS, LIOE-FEE DE GEUS-OEI, NIELKA P. VAN ERP and WINETTE TA VAN DER GRAAF

Anticancer Research March 2019, 39 (3) 1309-1316; DOI: https://doi.org/10.21873/anticanres.13243
You have access
Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer
ANA LAURA ORTEGA-GRANADOS, ÁNGEL ARTAL-CORTES, DAVID AGUIAR-BUJANDA, JUANA ORAMAS, JOSÉ LUIS FÍRVIDA, JAVIER DE CASTRO, JUANA CAMPILLO FUENTES, ROCÍO GORDO, RAQUEL GALÁN, JOSÉ TRIGO and on behalf of the ASPET Study Investigators

Anticancer Research March 2019, 39 (3) 1317-1328; DOI: https://doi.org/10.21873/anticanres.13244
You have access
Interstitial Brachytherapy in Combination With Previous Transarterial Embolization in Patients With Unresectable Hepatocellular Carcinoma
DIRK SCHNAPAUFF, BRUNO R. TEGEL, MACIEJ J. POWERSKI, FEDERICO COLLETINI, BERND HAMM and BERNHARD GEBAUER

Anticancer Research March 2019, 39 (3) 1329-1336; DOI: https://doi.org/10.21873/anticanres.13245
You have access
Extensive Lymph Node Dissection Around the Left Laryngeal Nerve Achieved With Robot-assisted Thoracoscopic Esophagectomy
SATORU MOTOYAMA, YUSUKE SATO, AKIYUKI WAKITA, YUTA KAWAKITA, YUSHI NAGAKI, KAZUHIRO IMAI and YOSHIHIRO MINAMIYA

Anticancer Research March 2019, 39 (3) 1337-1342; DOI: https://doi.org/10.21873/anticanres.13246
You have access
Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses
HEINKE C. HANSEN, STEFAN JANSSEN, CATHRIN THIEME, ALEKSEJ PERLOV, STEVEN E. SCHILD and DIRK RADES

Anticancer Research March 2019, 39 (3) 1343-1346; DOI: https://doi.org/10.21873/anticanres.13247
You have access
Early Neuropathy Related to Oxaliplatin Treatment in Advanced and Recurrent Colorectal Cancer
TOMOYUKI NAGATA, KEN-ICHIRO FUKUDA, MIZUKI TAMAI, AKIHIRO TANIGUCHI, HAJIME KAMIYA, KOSUKE KAMBE, YOSUKE KAMADA, GEORGE IWATA and NOBUKI YAMAOKA

Anticancer Research March 2019, 39 (3) 1347-1353; DOI: https://doi.org/10.21873/anticanres.13248
You have access
Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment
YEN-TING LIU, CHUN-WEI WANG, RUEY-LONG HONG and SUNG-HSIN KUO

Anticancer Research March 2019, 39 (3) 1355-1364; DOI: https://doi.org/10.21873/anticanres.13249
You have access
Thermochemoradiotherapy Using Superselective Intra-arterial Infusion for Patients With Oral Cancer With Cervical Lymph Node Metastases
TOMOYO NOZATO, TOSHIYUKI KOIZUMI, YUICHIRO HAYASHI, MASAKI IIDA, TOSHINORI IWAI, SENRI OGURI, MAKOTO HIROTA, MITOMU KIOI, IZUMI KOIKE, MASAHARU HATA, IWAI TOHNAI and KENJI MITSUDO

Anticancer Research March 2019, 39 (3) 1365-1373; DOI: https://doi.org/10.21873/anticanres.13250
You have access
Healthcare Costs for High-grade Glioma
YANG LIU, EVAN TYLER, MARTIN LUSTICK, DAVID KLEIN and KEVIN A. WALTER

Anticancer Research March 2019, 39 (3) 1375-1381; DOI: https://doi.org/10.21873/anticanres.13251
You have access
Rectus Sheath Block (RSB) Analgesia Could Enhance Significantly the Patient Satisfaction Following Midline Laparotomy in Benign Disease and in Cancer: A Prospective Study With Special Reference to Nitrosative Stress Marker Nitrotyrosine (NT) Plasma Concentrations
VIIVI KUOSMANEN, IINA SAIMANEN, DINA RAHKOLA, JARI KÄRKKÄINEN, TUOMAS SELANDER, MARTIN PURDY, HANNU KOKKI, MERJA KOKKI and MATTI ESKELINEN

Anticancer Research March 2019, 39 (3) 1383-1389; DOI: https://doi.org/10.21873/anticanres.13252
You have access
Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive Prostate Cancer
HIDEAKI MIYAKE, YUTO MATSUSHITA, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, TOSHIKI ITO, TAKAYUKI SUGIYAMA and ATSUSHI OTSUKA

Anticancer Research March 2019, 39 (3) 1391-1396; DOI: https://doi.org/10.21873/anticanres.13253
You have access
Prostate Cancer Diagnosis and Management Across Twenty Years of Clinical Practice: A Single-center Experience on 2,500 Cases
PIETRO PEPE and MICHELE PENNISI

Anticancer Research March 2019, 39 (3) 1397-1401; DOI: https://doi.org/10.21873/anticanres.13254
You have access
Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study
BYOUNG CHUL CHO, TOMMASO DE PAS, HARALABOS KALOFONOS, QUN WANG, RODRYG RAMLAU, YING CHENG, FABIANA VITIELLO, TANEL LAISAAR, ERIC VALLIÈRES, BARTOSZ KUBISA, SERGEY ORLOV, KEUNCHIL PARK, CHANNA DEBRUYNE and JOHAN VANSTEENKISTE

Anticancer Research March 2019, 39 (3) 1403-1409; DOI: https://doi.org/10.21873/anticanres.13255
You have access
Short- and Long-term Outcomes of Surgical Treatment for Remnant Gastric Cancer After Distal Gastrectomy
YU NAKAJI, HIROSHI SAEKI, KENSUKE KUDOU, RYOTA NAKANISHI, MASAHIKO SUGIYAMA, YUICHIRO NAKASHIMA, KOJI ANDO, YOSHINAO ODA, EIJI OKI and YOSHIHIKO MAEHARA

Anticancer Research March 2019, 39 (3) 1411-1415; DOI: https://doi.org/10.21873/anticanres.13256
You have access
Prediction of Liver Fibrosis Using CT Under Respiratory Control: New Attempt Using Deformation Vectors Obtained by Non-rigid Registration Technique
AKIHIRO NISHIE, SADATO AKAHORI, YOSHIKI ASAYAMA, KOUSEI ISHIGAMI, YASUHIRO USHIJIMA, DAISUKE KAKIHARA, TOMOHIRO NAKAYAMA, YUKIHISA TAKAYAMA, NOBUHIRO FUJITA, KOICHIRO MORITA, KEISUKE ISHIMATSU, SEIICHIRO TAKAO, TOMOHARU YOSHIZUMI, KENICHI KOHASHI, YUANZHONG LI and HIROSHI HONDA

Anticancer Research March 2019, 39 (3) 1417-1424; DOI: https://doi.org/10.21873/anticanres.13257
You have access
Molecular Subtypes Are Frequently Discordant Between Lesions in Patients With Synchronous Colorectal Cancer: Molecular Analysis of 59 Patients
KEIICHI ARAKAWA, KEISUKE HATA, HIROAKI NOZAWA, KAZUSHIGE KAWAI, TOSHIAKI TANAKA, TAKESHI NISHIKAWA, KAZUHITO SASAKI, YASUTAKA SHUNO, MANABU KANEKO, MASAYA HIYOSHI, SHIGENOBU EMOTO, KOJI MURONO, HIROFUMI SONODA, SATOSHI OKADA and SOICHIRO ISHIHARA

Anticancer Research March 2019, 39 (3) 1425-1432; DOI: https://doi.org/10.21873/anticanres.13258
You have access
Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma
YOICHI HAMAI, MANABU EMI, YUTA IBUKI, YUJI MURAKAMI, IKUNO NISHIBUCHI, YASUSHI NAGATA, TAKAOKI FURUKAWA, TOMOAKI KUROKAWA, MANATO OHSAWA and MORIHITO OKADA

Anticancer Research March 2019, 39 (3) 1433-1440; DOI: https://doi.org/10.21873/anticanres.13259
You have access
Preoperative Albumin-Bilirubin Grade as a Useful Prognostic Indicator in Patients With Pancreatic Cancer
TAKUKI YAGYU, HIROAKI SAITO, TERUHISA SAKAMOTO, EI UCHINAKA, MASAKI MORIMOTO, MASATAKA AMISAKI, JOJI WATANABE, NARUO TOKUYASU, SOICHIRO HONJO, KEIGO ASHIDA and YOSHIYUKI FUJIWARA

Anticancer Research March 2019, 39 (3) 1441-1446; DOI: https://doi.org/10.21873/anticanres.13260
You have access
One-step Nucleic Acid Amplification Can Identify Sentinel Node-negative Breast Cancer Patients With Excellent Prognosis
KENZO SHIMAZU, TOMOHIRO MIYAKE, JUN OKUNO, YASUTO NAOI, TOMONORI TANEI, MASAFUMI SHIMODA, NAOFUMI KAGARA, SEUNG JIN KIM and SHINZABURO NOGUCHI

Anticancer Research March 2019, 39 (3) 1447-1454; DOI: https://doi.org/10.21873/anticanres.13261
You have access
Post-treatment Glasgow Prognostic Score Predicts Efficacy in Advanced Non-small-cell Lung Cancer Treated With Anti-PD1
NORIMITSU KASAHARA, NORIAKI SUNAGA, YUSUKE TSUKAGOSHI, YOSUKE MIURA, REIKO SAKURAI, SHINSUKE KITAHARA, TAKEHIKO YOKOBORI, KYOICHI KAIRA, AKIRA MOGI, TOSHITAKA MAENO, TAKAYUKI ASAO and TAKESHI HISADA

Anticancer Research March 2019, 39 (3) 1455-1461; DOI: https://doi.org/10.21873/anticanres.13262
You have access
Carboplatin Plus Nab-paclitaxel in Performance Status 2 Patients With Advanced Non-small-cell Lung Cancer
KAZUHISA NAKASHIMA, HIROAKI AKAMATSU, HARUYASU MURAKAMI, TAKASHI NIWA, YASUO IWAMOTO, YUICHI OZAWA, TOSHIHIDE YOKOYAMA, HIROYASU SHODA, NOBUYUKI YAMAMOTO, HIROSHIGE YOSHIOKA, KEN MASUDA, TATEAKI NAITO, KEITA MORI and TOSHIAKI TAKAHASHI

Anticancer Research March 2019, 39 (3) 1463-1468; DOI: https://doi.org/10.21873/anticanres.13263
You have access
Combination of Distance from Superior Mesenteric Artery and Serum CA19-9 as a Novel Prediction of Local Recurrence in Patients With Pancreatic Cancer Following Resection
FUMITAKE SUZUKI, YUKI FUJIWARA, RYOGA HAMURA, KOICHIRO HARUKI, TARO SAKAMOTO, HIROAKI SHIBA and KATSUHIKO YANAGA

Anticancer Research March 2019, 39 (3) 1469-1478; DOI: https://doi.org/10.21873/anticanres.13264
You have access
Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated With Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis
CHIA-CHIN LI, JI-AN LIANG, CHIH-YUAN CHUNG, WILLIAM TZU-LIANG CHEN and CHUN-RU CHIEN

Anticancer Research March 2019, 39 (3) 1479-1484; DOI: https://doi.org/10.21873/anticanres.13265
You have access
Prognostic Significance of Lymph Node Dissection Along the Upper-third-stomach in Patients With Lower-third Gastric Cancer
RYO SAITO, YOSHIHIKO KAWAGUCHI, HIDENORI AKAIKE, KENSUKE SHIRAISHI, SUGURU MARUYAMA, HIROKI SHIMIZU, SHINJI FURUYA, NAOHIRO HOSOMURA, HIDETAKE AMEMIYA, HIROMICHI KAWAIDA, MAKOTO SUDO, SHINGO INOUE, HIROSHI KONO and DAISUKE ICHIKAWA

Anticancer Research March 2019, 39 (3) 1485-1489; DOI: https://doi.org/10.21873/anticanres.13266
You have access
Analysis of Histological Grade in Resected Lung-invasive Adenocarcinoma
MOTOAKI YASUKAWA, CHIHO OHBAYASHI, TAKESHI KAWAGUCHI, NORIKAZU KAWAI, TOKIKO NAKAI, NORIYOSHI SAWABATA and SHIGEKI TANIGUCHI

Anticancer Research March 2019, 39 (3) 1491-1500; DOI: https://doi.org/10.21873/anticanres.13267
You have access
Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM
DIRK RADES, LENA SEHMISCH, HEINKE C. HANSEN, LIESA DZIGGEL, STEFAN JANSSEN and STEVEN E. SCHILD

Anticancer Research March 2019, 39 (3) 1501-1505; DOI: https://doi.org/10.21873/anticanres.13268
You have access
ABSTRACTS OF THE 29th ANNUAL MEETING OF THE ITALIAN SOCIETY OF URO-ONCOLOGY (SIUrO)
Anticancer Research March 2019, 39 (3) 1507-1629; DOI: https://doi.org/10.21873/anticanres.13470

BOOK REVIEWS

You have access
Book Reviews
Anticancer Research March 2019, 39 (3) 1631;
You have access
Cancer Driver Genes
Anticancer Research March 2019, 39 (3) 1631;
You have access
Cell-free DNA as Diagnostic Markers
Anticancer Research March 2019, 39 (3) 1631;
You have access
Epitranscriptomics
Anticancer Research March 2019, 39 (3) 1631;
You have access
Hepatic Stem Cells
Anticancer Research March 2019, 39 (3) 1631;
You have access
Decellularized Scaffolds and Organogenesis
Anticancer Research March 2019, 39 (3) 1631-1632;
You have access
Introduction to Bioinformatics in Microbiology
Anticancer Research March 2019, 39 (3) 1632;
You have access
Pericyte Biology - Novel Concepts
Anticancer Research March 2019, 39 (3) 1632;
You have access
Alternatives to Animal Testing
Anticancer Research March 2019, 39 (3) 1632;
You have access
Immunotherapy of Sarcoma
Anticancer Research March 2019, 39 (3) 1632;
You have access
Multifunctional Nanoprobes. From Design Validation to Biomedical Applications
Anticancer Research March 2019, 39 (3) 1632-1633;
You have access
Cancer and AIDS. Part I: An Historical Perspective
Anticancer Research March 2019, 39 (3) 1633;
You have access
Synthesis of Therapeutic Oligonucleotides
Anticancer Research March 2019, 39 (3) 1633;
You have access
Oxford Case Histories in Lung Cancer
Anticancer Research March 2019, 39 (3) 1633;
You have access
Hybrid Nanostructures for Cancer Theranostics
Anticancer Research March 2019, 39 (3) 1633;

Main menu

User menu

Search

Index by author

Reviews

Experimental Studies

Clinical Studies

BOOK REVIEWS

In this issue

Jump to